Mercaptopurine

Chemical formula: C₅H₄N₄S  Molecular mass: 152.177 g/mol  PubChem compound: 667490

Therapeutic indications

Mercaptopurine is indicated for:

Acute lymphoblastic leukaemia (ALL)

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

Mercaptopurine is indicated for the treatment of acute lymphoblastic leukaemia (ALL) in adults, adolescents and children.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Mercaptopurine is contraindicated in the following cases:

Hypersensitivity to mercaptopurine

Mercaptopurine allergy

Lactation

Lactation

Yellow fever vaccine

Yellow fever vaccines

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2019: XALUPRINE Oral suspension
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈